Global (United States, European Union and China) Diabetes Management Devices Market Research Report 2019-2025

Diabetes management devices include insulin delivery systems and blood glucose monitoring devices, which are used to treat diabetes effectively and efficiently with fewer side effects. Diabetes (type 1 and type 2) is a chronic disease condition, which occurs due to glucose impairment. The major factors contributing to the disease include obesity, urbanization, sedentary lifestyle, smoking, an elevated level of cholesterols, and hypertension. Vendors in this market are offering high-end insulin delivery systems (less invasive, sleek, pocket-sized, and portable devices) and continuous glucose monitoring systems, which are highly efficient and have user-friendly features.
Diabetes is a chronic disease and is increasing at a rapid pace across the world. It is that state in the body when the pancreas cannot produce sufficient insulin. Increasing blood sugar level can be a threat and can cause severe damage to the body. The study identifies rising global burden of diabetes as one of the primary growth factors for diabetes management devices market. Factors responsible for increase in diabetic population include obesity, smoking, sedentary lifestyle, and growing urbanization. Older people above 65 years are more prone to diabetes. Countries such as China and India have higher diabetic people due to the increase in obesity and urbanization. Owing to the increase in diabetic population across the world, there is increase in adoption of diabetes management devices. 
Owing to the presence of several large and small players, the diabetes management devices market is highly competitive. To sustain the competition in the diabetes devices market, the vendors are heavily investing in R&D for designing, developing, and manufacturing innovative products. Currently, the emerging markets across the globe provide huge growth opportunities to the vendors in this marketspace.
The Americas will be the major revenue contributor to the diabetes management devices market throughout the forecast period. Owing to the advancements in technology and the increasing incidence of type 1 and type 2 diabetes, there is an upsurge in the adoption of diabetes management devices in this region.
In 2019, the market size of Diabetes Management Devices is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Diabetes Management Devices. 

This report studies the global market size of Diabetes Management Devices, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Diabetes Management Devices production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered: 
    Abbott
    Dexcom
    F. Hoffmann-La Roche
    LifeScan
    Medtronic
    AgaMatrix
    Animas
    ARKRAY
    Ascensia Diabetes Care
    B. Braun Melsungen
    BD
    Beta Bionics
    Bigfoot Biomedical
    BIONIME USA
    CellNovo
    Eli Lilly
    iHealth Labs
    Insulet
    Nemaura Medical
    Nipro
    Nova Biomedical
    Novo Nordisk
    Panasonic Healthcare
    Prodigy Diabetes Care
    Sanofi
    Senseonics
    Tandem Diabetes Care
    Trividia Health
    TypeZero Technologies
    Valeritas
    WellDoc

Market Segment by Product Type
    Blood glucose monitoring device
    Insulin delivery systems

Market Segment by Application
    Hospitals
    Clinics and laboratories
    Others

Key Regions split in this report: breakdown data for each region.
    United States
    China
    European Union
    Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
    To analyze and research the Diabetes Management Devices status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
    To present the key Diabetes Management Devices manufacturers, presenting the sales, revenue, market share, and recent development for key players.
    To split the breakdown data by regions, type, companies and applications 
    To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
    To identify significant trends, drivers, influence factors in global and regions
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Diabetes Management Devices are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025